Capital Flow Monitor · Sponsors · CIK 1882782

Odyssey Therapeutics, Inc.

51 SLEEPER STREET, BOSTON, MA, 02210 · 617-865-9628

Biotechnology · Corporation· inc. DELAWARE true 2021

Fit score

—

Offering

$214.0M

Sold

$214.0M

% sold

100.0%

Investors

55

Min investment

$0

Exemption

506(b)

Filing history

FiledFormRuleOfferingSold% soldInvestors
2025-12-04 D ·current 506(b) $214.0M $214.0M 100.0% 55 EDGAR ↗

Related persons

Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.

Placement agents

  • No sales compensation reported — direct raise.

Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.